These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study. Jaakkola J; Jaakkola S; Airaksinen KEJ; Husso A; Juvonen T; Laine M; Virtanen M; Maaranen P; Niemelä M; Mäkikallio T; Savontaus M; Tauriainen T; Valtola A; Vento A; Eskola M; Raivio P; Biancari F PLoS One; 2020; 15(9):e0238953. PubMed ID: 32915895 [TBL] [Abstract][Full Text] [Related]
14. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management. Megaly M; Garcia S; Anzia LE; Morley P; Garberich R; Gornick CC; Lesser J; Sorajja P; Gössl M; Sengupta J J Invasive Cardiol; 2019 Jul; 31(7):E177-E183. PubMed ID: 31257211 [TBL] [Abstract][Full Text] [Related]
15. Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials. Brener MI; George I; Kosmidou I; Nazif T; Zhang Z; Dizon JM; Garan H; Malaisrie SC; Makkar R; Mack M; Szeto WY; Fearon WF; Thourani VH; Leon MB; Kodali S; Biviano AB J Am Heart Assoc; 2021 Apr; 10(7):e019584. PubMed ID: 33754803 [TBL] [Abstract][Full Text] [Related]
16. Atrial Fibrillation and Outcomes After Transcatheter or Surgical Aortic Valve Replacement (from the PARTNER 3 Trial). Shahim B; Malaisrie SC; George I; Thourani VH; Biviano AB; Russo MJ; Brown DL; Babaliaros V; Guyton RA; Kodali SK; Nazif TM; McCabe JM; Williams MR; Généreux P; Lu M; Yu X; Alu MC; Webb JG; Mack MJ; Leon MB; Kosmidou I Am J Cardiol; 2021 Jun; 148():116-123. PubMed ID: 33691183 [TBL] [Abstract][Full Text] [Related]
17. Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry. Tanawuttiwat T; Stebbins A; Marquis-Gravel G; Vemulapalli S; Kosinski AS; Cheng A J Am Heart Assoc; 2022 Jan; 11(1):e023561. PubMed ID: 34970918 [TBL] [Abstract][Full Text] [Related]
18. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement. Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844 [TBL] [Abstract][Full Text] [Related]
19. Impact of sinus rhythm versus atrial fibrillation on left ventricular remodeling after transcatheter aortic valve replacement. Ledwoch J; Fröhlich C; Olbrich I; Poch F; Thalmann R; Fellner C; Bradaric C; Laugwitz KL; Kupatt C; Hoppmann P Clin Res Cardiol; 2021 May; 110(5):689-698. PubMed ID: 33566184 [TBL] [Abstract][Full Text] [Related]
20. Transcatheter Aortic Valve Replacement and Atrial Fibrillation: Impact of Antithrombotic Strategy on Clinical Outcomes. Hui S; Gooley R; Rashid HN; Zaman S Heart Lung Circ; 2019 May; 28(5):771-776. PubMed ID: 29691157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]